Home › Therapeutic areas › Oncology › Waldenstrom's Macroglobulinemia
Waldenstrom's Macroglobulinemia (2 companies)
Companies with an active program in Waldenstrom's Macroglobulinemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| CLRB | Cellectar Biosciences, Inc. | Oncology | 1 | NDA Submitted | 11 |
| NRIX | Nurix Therapeutics, Inc. | Oncology | 2 | Phase 2 | 13 |
No companies match.